138 related articles for article (PubMed ID: 9186847)
1. Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation.
Aye TT; Bartholomeusz A; Shaw T; Bowden S; Breschkin A; McMillan J; Angus P; Locarnini S
J Hepatol; 1997 May; 26(5):1148-53. PubMed ID: 9186847
[TBL] [Abstract][Full Text] [Related]
2. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
de Man RA; Bartholomeusz AI; Niesters HG; Zondervan PE; Locarnini SA
J Hepatol; 1998 Oct; 29(4):669-75. PubMed ID: 9824278
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with famciclovir against hepatitis B virus.
Bartholomeusz A; Groenen LC; Locarnini SA
Intervirology; 1997; 40(5-6):337-42. PubMed ID: 9675638
[TBL] [Abstract][Full Text] [Related]
4. Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance.
Pichoud C; Seignères B; Wang Z; Trépo C; Zoulim F
Hepatology; 1999 Jan; 29(1):230-7. PubMed ID: 9862871
[TBL] [Abstract][Full Text] [Related]
5. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP
Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of hepatitis B virus polymerase mutations associated with famciclovir resistance.
Xiong X; Yang H; Westland CE; Zou R; Gibbs CS
Hepatology; 2000 Jan; 31(1):219-24. PubMed ID: 10613749
[TBL] [Abstract][Full Text] [Related]
7. Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure.
Günther S; von Breunig F; Santantonio T; Jung MC; Gaeta GB; Fischer L; Sterneck M; Will H
J Hepatol; 1999 May; 30(5):749-54. PubMed ID: 10365797
[TBL] [Abstract][Full Text] [Related]
8. [B domain mutations in the polymerase gene of hepatitis B virus during combination therapy with thymosin alpha1 and famciclovir in Chinese asymptomatic HBV carriers].
Hou J; Wang Z; Sun J
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):574-6. PubMed ID: 11798819
[TBL] [Abstract][Full Text] [Related]
9. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation.
Singh N; Gayowski T; Wannstedt CF; Wagener MM; Marino IR
Transplantation; 1997 May; 63(10):1415-9. PubMed ID: 9175803
[TBL] [Abstract][Full Text] [Related]
10. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.
Krüger M; Tillmann HL; Trautwein C; Bode U; Oldhafer K; Maschek H; Böker KH; Broelsch CE; Pichlmayr R; Manns MP
Liver Transpl Surg; 1996 Jul; 2(4):253-62. PubMed ID: 9346658
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase gene.
Wolters LM; Honkoop P; Niesters HG; de Man RA
J Hepatol; 1998 May; 28(5):909-10. PubMed ID: 9625328
[No Abstract] [Full Text] [Related]
12. Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.
Mutimer D; Pillay D; Cook P; Ratcliffe D; O'Donnell K; Dowling D; Shaw J; Elias E; Cane PA
J Infect Dis; 2000 Feb; 181(2):713-6. PubMed ID: 10669360
[TBL] [Abstract][Full Text] [Related]
13. Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy.
Stuyver L; Van Geyt C; De Gendt S; Van Reybroeck G; Zoulim F; Leroux-Roels G; Rossau R
J Clin Microbiol; 2000 Feb; 38(2):702-7. PubMed ID: 10655370
[TBL] [Abstract][Full Text] [Related]
14. Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
Shapira R; Daudi N; Klein A; Shouval D; Mor E; Tur-Kaspa R; Dinari G; Ben-Ari Z
Transplantation; 2002 Mar; 73(5):820-2. PubMed ID: 11907436
[TBL] [Abstract][Full Text] [Related]
15. Famciclovir treatment in transplant recipients with HBV-related liver disease: disappointing results.
Berenguer M; Prieto M; Rayón M; Bustamante M; Carrasco D; Moya A; Pastor MA; Gobernado M; Mir J; Berenguer J
Am J Gastroenterol; 2001 Feb; 96(2):526-33. PubMed ID: 11232701
[TBL] [Abstract][Full Text] [Related]
16. Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B.
Seignères B; Pichoud C; Ahmed SS; Hantz O; Trépo C; Zoulim F
J Infect Dis; 2000 Apr; 181(4):1221-33. PubMed ID: 10762559
[TBL] [Abstract][Full Text] [Related]
17. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
Rayes N; Seehofer D; Hopf U; Neuhaus R; Naumann U; Bechstein WO; Neuhaus P
Transplantation; 2001 Jan; 71(1):96-101. PubMed ID: 11211203
[TBL] [Abstract][Full Text] [Related]
18. Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation.
Haller GW; Bechstein WO; Neuhaus R; Raakow R; Berg T; Hopf U; Neuhaus P
Transpl Int; 1996; 9 Suppl 1():S210-2. PubMed ID: 8959829
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation.
Rayes N; Seehofer D; Bechstein WO; Müller AR; Berg T; Neuhaus R; Neuhaus P
Clin Transplant; 1999 Dec; 13(6):447-52. PubMed ID: 10617232
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the hepatitis B virus polymerase gene associated with antiviral treatment for hepatitis B.
Hussain M; Lok AS
J Viral Hepat; 1999 May; 6(3):183-94. PubMed ID: 10607230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]